Trademarkia Logo

Canada

C$
Trademark Search in Canada
INGLEMIREPHARM'S & CHINESE CHARACTERS TRANSLITERATE TO 'YING SHU' & DEVICE
INGLEMIREPHARM'S & CHINESE CHARACTERS TRANSLITERATE TO 'YING SHU' & DEVICE
REGISTERED

on 20 Jan 2020

Last Applicant/ Owned by

ZHEJIANG YINGSHU BIOLOGICAL TECHNOLOGY CO. LTD.

BUILDING 6, FAR EAST ENTERPRISE CLUBS, YUYAO CITYZHEJIANG PROVINCE, 315400

CN

Serial Number

1869399 filed on 23rd Nov 2017

Registration Number

TMA1070265 registered on 20th Jan 2020

Registration expiry Date

20th Jan 2030

INGLEMIREPHARM'S & CHINESE CHARACTERS TRANSLITERATE TO 'YING SHU' & DEVICE

Trademark usage description

medicines for human purposes, for the treatment of injury of optic nerve; medicines for human purposes, for the treatment of functional constipation a Read More

Vienna Information


5 . 1 . 3

Trees or bushes of some other shapeArbres ou arbustes présentant une autre forme

5 . 1 . 16

Trees or bushes in stylized formArbres ou arbustes stylisés

5 . 1 . 5

One tree or one bushUn arbre ou un arbuste

26 . 4 . 1

SquaresCarrés

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 15

Quadrilaterals containing representations of animals or parts of animals' bodies or plantsQuadrilatères contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

28 . 3 . 0

Inscriptions in Chinese, Japanese or Korean charactersInscriptions en caractères chinois, japonais ou coréens

Classification Information


Class [005]
Medicines for human purposes, for the treatment of injury of optic nerve; Medicines for human purposes, for the treatment of functional constipation and for the intestinal cleaning preparation; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; Acetylsalicylic acid tablets; Medicines for human purposes, for the treatment of pruritus and alopecia; Medicines for human purposes, for weight loss; Medicines for human purposes, for hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the treatment of pain of muscle cramp caused by inflammation and injury; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and chronic gastritis; Medicines for human purposes, for the treatment of autoimmunity disease; Medicines for human purposes, for the treatment of infectious disease, namely liver infections, including hepatitis A, hepatitis B and hepatitis C, bloodstream infections, namely septicemia and bacteremia, central nervous system infections, eye infections, digestive system infections, respiratory infections, heart infections, urinary system infections, breast infections, reproductive system infections and cutaneous infections; dietetic substances adapted for medical use consisting of vitamins, minerals, amino acids and trace elements; depuratives for the body; dog washes, namely, insecticidal dog shampoo; insect repellent incense; babies' napkin-pants; teeth filling material; diapers for pets; food for babies; almond milk for pharmaceutical purposes; almond oils for pharmaceutical purposes.


Classification kind code

11

Mark Details


Serial Number

1869399

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 18th Dec 2019
Registration Pending
Submitted for opposition 191
on 18th Dec 2019
Registration Fee Notice Sent
Submitted for opposition 42
on 25th Sept 2019
Advertised
Submitted for opposition 26
on 3rd Sept 2019
Approved
Submitted for opposition 27
on 3rd Sept 2019
Approval Notice Sent
Submitted for opposition 22
on 6th Feb 2019
Search Recorded
Submitted for opposition 20
on 6th Feb 2019
Examiner's First Report
Submitted for opposition 31
on 29th Nov 2017
Formalized
Submitted for opposition 30
on 23rd Nov 2017
Filed
Submitted for opposition 1
on 23rd Nov 2017
Created